"Our mission is to provide you with personalized high-quality care. We are dedicated to improving and maintaining your health through preventative care and treating chronic diseases."

During the past decade, Treken Primary care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Treken Primary care" are "Narcolepsy" (2 trials), "Cataplexy Narcolepsy" (1 trials), "Excessive Daytime Sleepiness" (1 trials), "Narcolepsy With Cataplexy" (1 trials) and "Narcolepsy Without Cataplexy" (1 trials). Many other conditions were trialed in "Treken Primary care" in a lesser frequency.

Most popular intervention types in "Treken Primary care" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mazindol" (1 trials), "Placebo" (1 trials) and "mazindol extended release" (1 trials). Other intervention names were less common.

The vast majority of trials in "Treken Primary care" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Treken Primary care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Treken Primary care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Treken Primary care, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".